- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Potential Buyback Winners
Australian Pharmaceuticals & Biotech Potential Buyback Winners
UPDATED May 15, 2024
Most likely to generate positive returns on buybacks.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NEU | AU$21.80 | 12.9% | 50.4% | AU$2.7b | AU$26.13 | PE17.7x | E0.8% | n/a | ||
MSB | AU$1.03 | -6.0% | -10.9% | AU$1.2b | AU$1.10 | PS104.8x | E56.8% | n/a | ||
IMM | AU$0.43 | -6.5% | 20.8% | AU$529.0m | n/a | PS131.6x | E19.5% | n/a | ||
MVP | AU$0.43 | -3.4% | -44.9% | AU$36.7m | AU$3.66 | PS1.1x | E82.7% | 0% | ||
KZA | AU$0.08 | -27.3% | -17.5% | AU$18.9m | n/a | PS34068.4x | E49.6% | n/a |
Page 1 of 1